がん抑制遺伝子
出典・脚注

↑  Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986). “A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma”. Nature 323 (6089):  643-646. PMID 2877398.
↑  Knudson AG (2000). “Chasing the cancer demon”. Annu Rev Genet 34:  1-19. PMID 11092820.
↑  Lane DP (1992). “Cancer, p53, guardian of the genome”. Nature 358:  15-16. PMID 1614522.
↑  Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992). “Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours”. Nature 356 (6366):  215-221. PMID 1552940.
↑  Ko LJ, Prives C (1996). “p53: puzzle and paradigm”. Genes Dev 10 (9):  1054-1072. PMID 8654922.
↑  The Cancer Genome Atlas Research Network (2008). “Comprehensive genomic characterization defines human glioblastoma genes and core pathways”. Nature 455:  1061-1068.
↑  Classon M, Harlow E (2002). “The retinoblastoma tumour suppressor in development and cancer”. Nat Rev Cancer 2 (12):  910-917. PMID 12459729.
↑  Vousden KH, Lu X (2002). “Live or let die: the cell's response to p53”. Nat Rev Cancer 2 (8):  594-604. PMID 12154352.
↑  Vousden KH, Prives C (2005). “P53 and prognosis: new insights and further complexity”. Cell 120 (1):  7-10. PMID 15652475.
↑  Fearnhead NS, Britton MP, Bodmer WF (2001). “The ABC of APC”. Hum Mol Genet 10 (7):  721-733. PMID 11257105.
↑  Shen MH, Harper PS, Upadhyaya M (1996). “Molecular genetics of neurofibromatosis type 1 (NF1)”. J Med Genet 33 (1):  2-17. PMID 8825042.
↑  Rouleau GA et al. (1993). “Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2”. Nature 363 (6429):  515-521. PMID 8379998.
↑  Haber DA, Buckler AJ (1992). “WT1: a novel tumor suppressor gene inactivated in Wilms' tumor”. New Biol 4 (2):  97-106. PMID 1313285.
↑  Kaelin WG Jr. (2002). “Molecular basis of the VHL hereditary cancer syndrome”. Nat Rev Cancer 2 (9):  673-682. PMID 12209156.
1 2  Venkitaraman AR (2002). “Cancer susceptibility and the functions of BRCA1 and BRCA2”. Cell 108 (2):  171-182. PMID 11832208.
↑  Nevanlinna H, Bartek J (2006). “The CHEK2 gene and inherited breast cancer susceptibility”. Oncogene 25 (43):  5912-5919. PMID 16998506.
↑  Khalkhali-Ellis Z (2006). “Maspin: the new frontier”. Clin Cancer Res 12 (24):  7279-7283. PMID 17189399.
↑  Davis PK, Dowdy SF (2001). “p73”. Int J Biochem Cell Biol 33 (10):  935-939. PMID 11470228.
↑  Miyaki M, Kuroki T (2003). “Role of Smad4 (DPC4) inactivation in human cancer”. Biochem Biophys Res Commun 306 (4):  799-804. PMID 12821112.
↑  Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993). “The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer”. Cell 75 (5):  1027-1038. PMID 8252616.
↑  Niv Y (2007). “Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer”. World J Gastroenterol 13 (12):  1767-1769. PMID 17465465.
↑  Nicolaides NC et al. (1994). “Mutations of two PMS homologues in hereditary nonpolyposis colon cancer”. Nature 371 (6492):  75-80. PMID 8072530.
↑  Arakawa H (2004). “Netrin-1 and its receptors in tumorigenesis”. Nat Rev Cancer 4 (12):  978-87. PMID 15573119.
↑  Simpson L, Parsons R (2001). “PTEN: life as a tumor suppressor”. Exp Cell Res 264 (1):  29-41. PMID 11237521.
↑  Gottlieb E, Tomlinson IP (2005). “Mitochondrial tumour suppressors: a genetic and biochemical update”. Nat Rev Cancer 5 (11):  857-866. PMID 16327764.
↑  Smith-Sørensen B, Hovig E (1996). “CDKN2A (p16INK4A) somatic and germline mutations”. Hum Mutat 7 (4):  294-303. PMID 8723678.
↑  Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ (1995). “p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene”. Genes Dev 9 (6):  650-662. PMID 7729684.
↑  Hahn H et al. (1996). “Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome”. Cell 85 (6):  841-851. PMID 8681379.
↑  van Slegtenhost M et al. (1997). “Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34”. Science 277 (5327):  805-808. PMID 9242607.
↑  Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR, Cheadle JP (1997). “Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis”. Hum Mol Genet 6 (12):  2155-2161. PMID 9328481.
↑  Ahn J, Lüdecke HJ, Lindow S, Horton WA, Lee B, Wagner MJ, Horsthemke B, Wells DE (1995). “Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)”. Nat Genet 11 (2):  137-143. PMID 7550340.
↑  Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA (1996). “The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes”. Nat Genet 14 (1):  25-32. PMID 8782816.